Engineered Bilayer Hydrogel with Spatiotemporal Drug and Oxygen Delivery for Diabetic Wound Microenvironment Reprogramming
December 2025
in “
Regenerative Biomaterials
”
TLDR The hydrogel effectively heals diabetic wounds by reducing inflammation, providing oxygen, and preventing infection.
This study introduces an innovative bilayer hydrogel (Ca@Q-E@SGH) designed for diabetic wound healing by addressing inflammation, hypoxia, and infection. The hydrogel features a core component that releases EGCG in response to ROS/glucose, promoting macrophage transition from M1 to M2 to reduce inflammation. It also provides sustained oxygen release to aid vascularization during tissue remodeling. The bilayer structure offers protective functions, with a lower layer encapsulating nanoparticles and an upper layer preventing pathogen adhesion. This approach achieved a 99.1% wound closure rate by day 14, demonstrating a comprehensive strategy for diabetic wound management through intelligent drug release, oxygen delivery, and anti-fouling protection.